Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2020 - 12 - 31    crawled time : 13:03    save search

Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia
Published: 2020-12-31 (Crawled : 13:03) - globenewswire.com
LXRX | $1.705 -0.29% 530K twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 9.63% C: 3.64%

phase 2
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

EDBL | News | $6.75 79.52% 1.5M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology

OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance

MLEC | $1.81 29.29% 2M twitter stocktwits trandingview |
n/a

CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing

MTC | $2.0 28.21% 1.7M twitter stocktwits trandingview |
Technology Services

PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.